Letters Hepatitis B vaccine shortage

Hepatitis B vaccine shortage: another symptom of chronic neglect?

BMJ 2017; 359 doi: https://doi.org/10.1136/bmj.j4686 (Published 19 October 2017) Cite this as: BMJ 2017;359:j4686
  1. Philippa C Matthews, Wellcome Trust clinical research fellow and honorary consultant in infectious diseases and microbiology,
  2. Eleanor Barnes, professor of hepatology and experimental medicine and MRC senior fellow
  1. Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford OX1 3SY, UK
  1. philippa.matthews{at}ndm.ox.ac.uk

Current shortages of the hepatitis B virus vaccine have created media interest, including in The BMJ.1 Hepatitis B should make headlines; an estimated 250 million people are chronically infected, and funding, political advocacy, research, and clinical services have been neglected. International sustainable development goals aspire towards elimination of viral hepatitis as a public health threat by 2030.2 Vaccination is a crucial component of the multipronged effort needed to meet these targets.

Hepatitis B vaccine for routine infant vaccination …

View Full Text

Sign in

Log in through your institution

Subscribe